Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 2, 2002, Pages 606-611

  Crissman, Alicia M ^a   O'Donnell, James M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BETA 1 ADRENERGIC RECEPTOR; BETAXOLOL; BUSPIRONE; DESIPRAMINE; FLUOXETINE; ISOPRENALINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; N ACETYLTRYPTOPHAN; N(G) NITROARGININE; NISOXETINE; NORADRENALIN UPTAKE INHIBITOR; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ACTIVITY; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CEREBRAL VENTRICLES; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, PARENTERAL; ISOPROTERENOL; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036070595     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.034686     Document Type: Article

References (42)

1. Interaction of some atypical antidepressants and adrenoceptor antagonists with imipramine: A behavioral study with isoprenaline-induced drinking
2. Bupropion: A review of its mechanism of antidepressant activity
3. Perturbation of rat brain serotonergic systems results in an inverse relation between substance P and serotonin concentrations measured in discrete nuclei
4. Effects of sequential removal of rats from a group cage and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions
5. Review of bupropion
6. Discriminative stimulus effects of centrally administered isoproterenol in rats: Mediation by β1-adrenergic receptors
7. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats
8. Bupropion: A new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic β-adrenergic, serotonergic, α1-adrenergic, imipramine and dopaminergic receptors in brain
9. A comparison of the neurochemical and behavioral effects of elenbuterol and desipramine
10. Attempt at pharmacological differentiation of central β-adrenergic receptors
11. Reserpine-induced hypothermia: Participation of β1 and β2-adrenergic receptors
12. Pharmacologic mechanisms of action of antidepressants
13. Enhancement of monoaminergic neurotransmission by antidepressant drugs
14. Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of β-adrenergic recognition sites in rat frontal cortex
15. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test
16. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in down regulation of cortical β-adrenoceptors
17. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
18. Effects of antidepressant drugs in rats trained to discriminate the β2-adrenergic agonist clenbuterol from saline
19. Shuttle-box deficits induced by inescapable shocks in rats: Reversal by the β adrenoreceptor stimulants clenbuterol and salbutamol
20. 2 receptors in rat brain
21. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis
22. Acute tryptophan depletion: A method of studying antidepressant action
23. β1 and β2-adrenergic receptors in rat cerebral cortex are independently regulated
24. Down-regulation of the central noradrenergic receptor system by antidepressant therapies: Biochemical and clinical aspects
25. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression
26. Effects of clenbuterol and prenalterol on performance during differential reinforcement of low response rate in the rat
27. Behavioral effects of β-adrenergic agonists and antidepressants after down-regulation of β2-adrenergic receptors
28. Differential sensitivity to the effects of albuterol on locomotor activity and operant behavior
29. Involvement of β1 and β2-adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol
30. Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate
31. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine
32. Quantitative autoradiography of central β adrenoceptor subtypes: Comparison of the effects of chronic treatment with desipramine or centrally administered 1-isoproterenol
33. 125I-iodopindolol to β1 adrenoceptors in the amygdala of rat after antidepressant treatments
34. Effects of imipramine on serotonergic and β-adrenergic receptor binding in a realistic animal model of depression
35. The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats
36. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats
37. Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat
38. Variability of chronic antidepressant treatments on β-adrenergic receptor sites
39. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms
40. Noradrenergic activity differentially regulates the expression of rolipramsensitive, high affinity cyclic AMP phosphodiesterase (PDE4) in rat brain
41. Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain